Hospital Pharmacist role - Risk analysis for new therapeutics production

The roundtable titled “Risk Analysis Related to the Preparation of New Biotherapies” will focus on the challenges associated with handling emerging therapies such as CAR-T cells, phages, and autologous serum. While these new biotherapies offer promising therapeutic prospects, it is crucial for pharmacists to assess the risks related to their preparation or reconstitution, including cross-contamination, risks to personnel, and environmental impacts. This discussion will bring together experts to explore risk management strategies, biological safety, and best practices to minimize the risks associated with the preparation and administration of these therapies in a hospital setting.